aDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg
bDepartment of Emergency Medicine, Sahlgrenska University Hospital, Gothenburg
cOccupational and Environmental Medicine
dPrimary Healthcare, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg
eRegionhälsan R&D Centre, Skaraborg Primary Care, Skövde
fDivision of Cardiovascular Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm
gDepartment of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg
hDepartment of Neurology, Sahlgrenska University Hospital, Gothenburg
iAcademic Primary Healthcare Center
jDivision of Family Medicine and Primary Care, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm
kDepartment of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden
Correspondence to Johan-Emil Bager, Department of Emergency Medicine, Sahlgrenska University Hospital, Gröna Stråket 2, 413 45 Gothenburg, Sweden. Tel: +46 31 343 98 41; e-mail: [email protected]
Abbreviations: ATC, Anatomic Therapeutic Chemical classification system; BP, blood pressure; DAG, directed acyclic graph; ESC, European Society of Cardiology; ESH, European Society of Hypertension; HbA1C, glycated haemoglobin; ICD-10, International Statistical Classification of Diseases, 10th revision; OAC, oral anticoagulant; SPCCD-SKA, The Swedish Primary Care Cardiovascular Database of Skaraborg; TTR, time in therapeutic range
Received 18 January, 2021
Revised 7 February, 2021
Accepted 9 February, 2021
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.jhypertension.com).
